Divigel(R) is a bioidentical, transdermal gel that is FDA approved for the treatment of moderate to severe vasomotor symptoms associated with menopause. The estrogen in Divigel(R) is derived from plant sources and is identical to the primary estrogen produced by a woman's ovaries before menopause. Divigel(R) is a quick-drying gel that is odorless when dry, and is available in convenient, individual-use packets. One packet of gel is applied daily to an area that measures approximately 5 x 7 inches on the thigh, the smallest application area compared to all other available gel or lotion estrogen products.1-4 After the gel is applied, it absorbs directly into the bloodstream without having to pass through the liver.
Divigel(R) was approved by the U.S. Food and Drug Administration (FDA) in June 2007.
Important Safety Information for Patients
The following are not all the possible risks for Divigel(R). Please see the full Prescribing Information and talk to your healthcare provider.
Estrogens increase the chance of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus. Your healthcare provider should check any unusual vaginal bleeding to find out the cause. In general, the addition of a progestin is recommended for women with a uterus to reduce the chance of getting cancer of the uterus.
Do not use estrogens, with or without progestins, to prevent heart disease, heart attacks or strokes. Using estrogens, with or without progestins, may increase your chance of getting heart attacks, strokes, breast cancer and blood clots.
Do not use estrogens, with or without prog
|SOURCE Upsher-Smith Laboratories, Inc.|
Copyright©2009 PR Newswire.
All rights reserved